Compumedics Limited(D & DJ Burton Holdings Pty Ltd.)
Drive Devilbiss Healthcare(Drive International LLC)
Fisher & Paykel Healthcare Limited
Koninklijke Philips N.V.
Resmed Inc.
Smiths Group Plc
Somnetics International Inc.
Vyaire Medical Inc.
ksm
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
The global positive airway pressure devices market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
Positive airway pressure (PAP) therapy is widely used in the treatment of obstructive sleep apnea (OSA) and snoring. It is also utilized in respiratory ventilation to improve the oxygenation of patients in intensive care units (ICUs). PAP devices include straps to position the mask, a hose or tube to connect the mask to a motor and an air filter to purify the air entering the nostrils. Nowadays, automatic PAP devices that rely on proprietary algorithms to adjust the pressure delivered noninvasively are gaining traction worldwide to treat OSA at home.
Positive Airway Pressure Devices Market Trends:
The growing prevalence of hypertension, depression, diabetes and heart disorders is increasing the risk of developing OSA among individuals. This, in confluence with the availability of favorable reimbursement policies, represents one of the key factors escalating the demand for PAP devices across the globe. Apart from this, the introduction of portable, travel-friendly PAP devices is also bolstering the growth of the market. Furthermore, the leading manufacturers are developing and introducing compact and convenient product variants with improved noise reduction features. They are also providing discount offers on various products available through online retail channels. Moreover, various studies conducted by healthcare institutes are suggesting that continuous PAP devices can treat type 1 respiratory failure in patients diagnosed with the coronavirus disease (COVID-19). This, along with a shortage in the supply of mechanical ventilators, is anticipated to influence the market positively.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global positive airway pressure devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and end user.
The report has also analysed the competitive landscape of the market with some of the key players being 3B Medical Inc., Apex Medical Corp., Compumedics Limited (D & DJ Burton Holdings Pty Ltd.), Drive Devilbiss Healthcare (Drive International LLC), Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Resmed Inc., Smiths Group Plc, Somnetics International Inc. and Vyaire Medical Inc.
Key Questions Answered in This Report
1. What was the size of the global positive airway pressure devices market in 2023?
2. What is the expected growth rate of the global positive airway pressure devices market during 2024-2032?
3. What has been the impact of COVID-19 on the global positive airway pressure devices market?
4. What are the key factors driving the global positive airway pressure devices market?
5. What is the breakup of the global positive airway pressure devices market based on the product type?
6. What is the breakup of the global positive airway pressure devices market based on the end user?
7. What are the key regions in the global positive airway pressure devices market?
8. Who are the key players/companies in the global positive airway pressure devices market?